BGB-HNSCC-201
Active, not recruiting
A Study of Tislelizumab in Combination With Investigational Agents in Participants With Head and Neck Squamous Cell Carcinoma
BeOne Study ID
BGB-HNSCC-201
ClinicalTrials.gov ID
EudraCT or EUCT Number
2023-503418-63-00
China Drug Trials ID
CTR20232123
Study Overview
Sex: All
Age: 18 Years / N/A
Accepts Healthy Volunteers? No
No Study Documents
Study Overview
Sex: All
Age: 18 Years / N/A
Accepts Healthy Volunteers? No
No Study Documents